EP300/CBP-IN-2
EP300/CBP-IN-2 is a potent EP300/CBP inhibitor that has good activity in vivo. EP300/CBP-IN-2 can be used for the research of cancer[1].
Product Specifications
CAS Number
2379527-49-6
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Isotope-Labeled Compounds
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
O=C1N(C2=CC(F)=C(C=C2)F)[C@@H](CCC1)C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@@H]6CC[C@H](CC6)OC([2H])([2H])[2H]
Molecular Formula
C30H29D3F2N4O3
Molecular Weight
537.62
References & Citations
[1]Fan L, et al. Deuterated benzimidazole compound and application thereof as EP300/CBP inhibitor. China, CN112574178A. 2021-03-30.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP52338PU-N 400 µL
KIAA0652 (ATG13) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC942233-100 1x 100 µL
Creatine Phosphokinase-BB (CK-BB) (CPTC-CKB-2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details